Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3274924 | 0.74 | TRPA1 (0.32) | — | |
| SCHEMBL1987502 | 0.74 | SMN1; SMN2 (0.34) | — | |
| SCHEMBL22939000 | 0.71 | CTSK (0.33) | CTSK | |
| SCHEMBL914584 | 0.71 | — | — | |
| SCHEMBL28642158 | 0.71 | SMN1; SMN2 (0.40) | — | |
| SCHEMBL9509607 | 0.70 | SMN1; SMN2 (0.31) | — | |
| SCHEMBL27350891 | 0.70 | — | — | |
| SCHEMBL7994499 | 0.70 | — | — | |
| SCHEMBL3544856 | 0.69 | CETP (0.33) | — | |
| SCHEMBL4744556 | 0.66 | KMT2A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1067118-B1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | GIVAUDAN SA (CH) | 2004-03-31 | — | — | EP | claimed |
| US-20020086901-A1 | CYCLOPENTYLALKYL-NITRILES | GIVAUDAN SA, A SWITZERLAND CORPORATION | 2002-07-04 | — | — | US | claimed |
| US-6410000-B1 | PERFUME | GIVAUDAN SA (CH) | 2002-06-25 | — | — | US | claimed |
| EP-1067118-A1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | Givaudan SA (CH) | 2001-01-10 | — | — | EP | claimed |
| EP-1067118-B1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | GIVAUDAN SA (CH) | 2004-03-31 | — | — | EP | disclosed |
| US-6441052-B1 | ALKANOL, ALDEHYDE, AND KETONE CYCLOPENTA DERIVATIVES; FRAGRANCES | GIVAUDAN SA (CH) | 2002-08-27 | — | — | US | disclosed |
| US-20020086901-A1 | CYCLOPENTYLALKYL-NITRILES | GIVAUDAN SA, A SWITZERLAND CORPORATION | 2002-07-04 | — | — | US | disclosed |
| US-6410000-B1 | PERFUME | GIVAUDAN SA (CH) | 2002-06-25 | — | — | US | disclosed |
| US-6399811-B1 | ORGANOLEPTIC | GIVAUDAN SA (CH) | 2002-06-04 | — | — | US | disclosed |
| EP-1067118-A1 | Cyclopentylalkyl-nitriles and the use of odoriferous cyclopentylalkyl derivatives as fragrances | Givaudan SA (CH) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020086901-A1 | CYCLOPENTYLALKYL-NITRILES | CCRL2, CBR1, CNR1 | TSHR 4054/4885CTSK 3778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.